The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Aldeyra Therapeutics Inc (NASDAQ: ALDX) closed at $2.18 up 0.93% from its previous closing price of $2.16. In other words, the price has increased by $0.93 from its previous closing price. On the day, 1.09 million shares were traded.
Ratios:
For a deeper understanding of Aldeyra Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 03 ’25 when PERCEPTIVE ADVISORS LLC sold 3,400,000 shares for $1.42 per share. The transaction valued at 4,828,000 led to the insider holds 5,875,851 shares of the business.
Machatha Stephen sold 16,041 shares of ALDX for $75,975 on Aug 12 ’24. The Chief Development Officer now owns 236,771 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the insider of the company, sold 10,834 shares for $4.74 each. As a result, the insider received 51,313 and left with 126,382 shares of the company.
Stock Price History:
Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -48.29%, while the 200-Day Moving Average is calculated to be -56.34%.
Shares Statistics:
A total of 59.65M shares are outstanding, with a floating share count of 58.16M. Insiders hold about 2.90% of the company’s shares, while institutions hold 54.37% stake in the company.
